Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
"I do have hope," Maxwell said
Risk Mitigation Strategies for Weight Management Practices Maintain detailed patient-specific documentation of why the commercially available product does not meet the patients needs Request written clarification from compounding pharmacies about their compliance procedures Ensure prescription forms explicitly document the significant difference determination Consider consulting with healthcare regulatory counsel to review your weight management protocols Stay informed about FDA updates regarding GLP-1 availability and compounding guidance Conclusion The trend of 503A compounding pharmacies marketing GLP-1s with additives to weight management providers presents both opportunities and significant compliance risks
Typically, health insurers do not provide coverage for these medications, particularly when prescribed off-label for conditions such as SUD that currently lack FDA approval (National Association of Insurance Commissioners, 2024)
10.1186/s13578-019-0322-5 16 DrayC.KnaufC.DaviaudD.WagetA.BoucherJ.BulonM.et al (2008)
Follow provider recommendations for long-term success
